demonstr
loss
signal
significantli
promot
accept
allogen
engraft
two
separ
transplant
model
without
promot
gener
immunosuppress
cell
fail
reject
allogen
tumor
defect
reject
balbc
allogen
skin
graft
recipi
signific
fraction
alloreact
cell
underw
apoptosi
follow
activ
wherea
enforc
express
bclxl
cell
restor
allograft
reject
format
allogen
memori
also
greatli
hamper
cell
lack
gene
adopt
transfer
memori
cell
fail
promot
reject
allogen
tumor
cell
led
significantli
delay
reject
skin
allograft
balbc
model
costimulatori
blockad
vivo
administr
cytotox
tlymphocyt
antigen
fusion
protein
synerg
defici
led
longterm
allogen
skin
graft
accept
overal
result
demonstr
play
import
role
primari
memori
cell
respons
allograft
sinc
previou
studi
demonstr
loss
neg
impact
antivir
immun
studi
underscor
potenti
util
pharmacolog
blockad
achiev
transplant
mainten
without
imposit
gener
immunosuppress
follow
transplant
organ
tissu
cell
popul
foreign
donor
recognit
polymorph
within
mhc
protein
term
allorecognit
typic
lead
cell
activ
destruct
allograft
current
allograft
reject
prevent
clinic
lifelong
administr
power
immunosuppress
cyclosporin
mani
instanc
drug
attend
toxic
issu
even
potent
immunosuppress
allogen
memori
cell
tmem
respons
proven
refractori
current
treatment
regimen
organ
failur
often
result
chronic
reject
mediat
allogen
tmem
therefor
allograft
recipi
must
live
chronic
immunosuppress
state
risk
deadli
opportunist
infect
chronic
reject
may
occur
present
known
intracellular
extracellular
target
may
exploit
specif
block
allograft
reject
without
impos
gener
immunosuppress
blockad
cell
costimulatori
ligand
shown
promis
prevent
allograft
reject
mice
especi
treatment
use
combin
blockad
remov
clinic
trial
due
thromboembol
complic
follow
administr
though
therapi
approv
block
certain
allorespons
explor
addit
therapeut
target
prevent
reject
without
detriment
effect
recipi
health
remain
imper
neg
regul
cell
activ
highli
enrich
b
cell
express
abolish
genet
delet
mice
develop
resist
organ
specif
cell
mediat
autoimmun
diseas
experiment
autoimmun
encephalomyel
eae
resist
typei
diabet
spontan
develop
nonobes
diabet
mous
background
cell
defici
readili
activ
suboptim
stimul
tcr
die
apoptosi
prior
accumul
importantli
previou
studi
shown
loss
signal
impair
antivir
immun
murin
hepat
viru
mhv
lymphocyt
choriomening
viru
lcmv
west
nile
viru
mice
also
develop
overtli
normal
tmem
popul
enhanc
function
per
cell
basi
follow
mhv
infect
studi
hypothes
blockad
may
serv
novel
approach
alter
cell
allorespons
notion
prompt
previou
studi
reveal
blockad
signal
molecul
promot
autoimmun
suscept
often
also
requir
cell
alloreact
use
two
differ
allogen
transplant
model
observ
loss
lead
signific
impair
allograft
reject
like
consequ
prematur
effector
cell
death
follow
allogen
stimul
loss
signal
drastic
reduc
develop
allogen
tmem
support
content
longterm
allograft
mainten
may
achiev
blockad
synerg
blockad
lead
enhanc
allograft
surviv
stringent
skin
transplant
model
discoveri
underscor
signific
blockad
achiev
allograft
toler
support
altern
mean
promot
allograft
surviv
without
impos
stringent
immunosuppress
backcross
onto
b
background
gener
describ
previous
bclxl
transgen
mice
gener
craig
thompson
lab
cross
gener
bclxl
purchas
tacon
hudson
ny
anim
studi
approv
institut
anim
care
use
committe
univers
california
irvin
reagent
use
flow
cytometri
includ
antiinterferongamma
ifng
biolegend
san
diego
ca
carboxyfluorescein
diacet
succinimidyl
ester
cfse
invitrogen
carlsbad
ca
intracellular
ifng
stain
describ
previous
adopt
transfer
retroorbit
inject
pure
cell
tmem
homeostat
prolifer
cell
permit
prior
tumor
transplant
allogen
tumor
instil
subcutan
flank
allogen
skin
balbc
ear
place
onto
flank
wt
follow
incis
skin
secur
steril
bandag
day
adopt
transfer
model
transplant
skin
first
follow
adopt
transfer
wildtyp
cell
day
later
treatment
mice
inject
microgram
day
follow
adopt
transfer
order
determin
loss
alter
cell
allorespons
mix
lymphocyt
reaction
mlr
perform
cultur
purifi
cfselabel
cell
b
allogen
balbc
splenocyt
cell
diminish
accumul
day
compar
wt
cell
fig
sinc
alter
tcr
sensit
test
variou
ratio
stimul
respond
mlr
cell
exhibit
diminish
prolif
capac
variou
ratio
demonstr
allogen
activ
absenc
signal
result
defect
allomlr
activ
fig
earlier
time
point
also
examin
cell
accumul
defect
manifest
earli
post
activ
although
statist
signific
differ
note
fig
mlr
cultur
stain
follow
stimul
detect
nonviabl
cell
ratio
cell
die
cycl
compar
live
cycl
cell
fig
cell
exhibit
enhanc
apoptosi
follow
allogen
stimul
defect
could
partial
rescu
addit
ab
modestli
late
costimulatori
signal
fig
cell
allorespons
test
vivo
use
allogen
tumor
transplant
model
wildtyp
cell
magnet
purifi
adopt
transfer
c
mice
lack
b
natur
killer
cell
follow
adopt
transfer
cell
underw
homeostat
prolifer
prior
allogen
tumor
challeng
defect
seen
reconstitut
sham
mice
cell
compar
wt
suppl
fig
b
allogen
tumor
cell
inocul
flank
b
express
wt
cell
recipi
tumor
growth
measur
time
mice
receiv
cell
fail
reject
allogen
tumor
seen
increas
tumor
growth
cours
fig
contrast
mice
bear
wildtyp
cell
display
rapid
reject
tumor
allograft
maxim
tumor
size
peak
roughli
post
transplant
prevent
effector
cell
teff
apoptosi
vivo
accomplish
cross
mice
carri
cell
specif
bclxl
transgen
follow
allogen
tumor
transplant
bclxl
express
cell
restor
abil
promot
alloreject
fig
tumor
growth
absenc
cell
rapid
cell
host
although
time
tumor
growth
regress
cell
transfer
fig
examin
cell
respons
follow
allogen
tumor
stimul
splenocyt
wt
receiv
situ
allogen
tumor
prior
retriev
day
post
transplant
chosen
peak
reject
respons
tumor
reject
situ
occur
similar
kinet
possibl
due
help
immun
cell
popul
ffig
secondari
restimul
ex
vivo
cell
cell
prolifer
almost
complet
absent
fig
vitro
restimul
cell
follow
tumor
reject
tumor
cell
reveal
drastic
reduc
product
cell
demonstr
alloreact
teff
left
follow
initi
activ
fig
fig
respons
tumor
antigen
factor
sinc
restimul
ex
vivo
allogen
splenocyt
yield
similar
result
fig
data
support
hypothesi
cell
undergo
abort
prolifer
due
prematur
cell
death
follow
allogen
activ
vivo
address
potenti
may
contribut
allospecif
memori
wt
inocul
situ
tumor
cell
spleen
retriev
later
purif
allogen
tmem
perform
magnet
deplet
antigen
present
cell
apc
cell
follow
adopt
transfer
c
host
wt
tmem
rapidli
reject
tumor
allotumor
challeng
fail
provok
strong
allogen
respons
fig
address
point
tmem
mix
allogen
tumor
elispot
assay
follow
cell
form
similar
number
elispot
vs
wt
suggest
initi
alloreact
repertoir
normal
fig
altern
popul
form
significantli
fewer
elispot
upon
restimul
fig
previou
report
defin
shortterm
effector
long
term
tmem
popul
base
surfac
express
upon
analysi
popul
previous
transplant
tumor
longterm
tmem
cell
number
significantli
diminish
compar
wt
fig
differ
memori
compart
note
although
differ
number
tmem
cell
statist
signific
data
highlight
overal
defect
allospecif
tmem
respons
seen
popul
experiment
transplant
skin
transplant
consid
one
stringent
test
allogen
transplant
toler
mice
follow
success
engraft
ear
skin
allogen
balbc
mice
onto
back
sign
graft
reject
monitor
daili
wildtyp
recipi
rapidli
reject
skin
graft
necrot
wherea
display
significantli
delay
reject
case
transplant
mainten
equival
prolong
previou
report
use
block
costimul
fig
although
reject
eventu
occur
model
strong
stimulatori
properti
skin
graft
may
promot
rescu
tmem
popul
address
role
strong
allostimul
format
collect
spleen
mice
reject
skin
graft
prior
follow
tmem
purif
transfer
c
host
wt
tmem
rapidli
reject
skin
graft
wherea
transfer
led
signific
delay
instanc
complet
lack
reject
fig
examin
phenotyp
tmem
popul
reveal
significantli
fewer
long
live
lo
hi
memori
cell
compart
nearli
fold
increas
hi
hi
cell
subset
vs
wt
mice
fig
also
note
diminish
recoveri
central
memori
cell
differ
seen
memori
popul
fig
b
cell
express
compar
level
suggest
diminish
function
due
clonal
exhaust
fig
previou
report
suggest
hi
hi
cell
intermedi
life
span
follow
viral
infect
although
futur
investig
aim
determin
function
capac
cell
allograft
reject
sinc
addit
costimulatori
antibodi
ab
mlr
cultur
enhanc
allorespons
curiou
potenti
synergist
effect
block
signal
costimul
allorespons
thu
treat
wt
day
follow
allogen
balbc
skin
transplant
assess
graft
surviv
time
block
costimul
increas
graft
surviv
time
wt
mice
sever
day
rescu
similar
observ
untreat
fig
howev
combin
defici
along
costimulatori
blockad
led
significantli
longer
graft
surviv
time
major
skin
graft
still
intact
specif
address
cell
intrins
requir
signal
skin
transplant
reject
cell
allorespons
balbc
skin
graft
adopt
transfer
model
investig
first
c
mice
transplant
balbc
skin
graft
follow
adopt
transfer
purifi
wt
cell
later
mice
bear
cell
exhibit
significantli
delay
skin
graft
reject
compar
bear
wt
cell
fig
administ
immedi
follow
adopt
transfer
continu
everi
day
post
adopt
transfer
similar
situ
model
skin
transplant
shown
earlier
cell
recipi
treat
maintain
skin
graft
without
sign
reject
fig
find
support
hypothesi
blockad
signal
synergist
promot
allograft
mainten
report
demonstr
signal
requir
product
cell
allorespons
two
separ
allogen
transplant
model
data
support
hypothesi
signal
requir
effici
alloreject
absenc
signal
prematur
teff
cell
death
lead
select
delet
alloreact
clone
prior
tmem
format
fig
importantli
surviv
defect
pronounc
cell
activ
presenc
low
level
costimul
base
previou
work
specul
highli
inflammatori
natur
complet
mhc
mismatch
skin
transplant
provid
environ
favor
surviv
fraction
alloreact
capabl
eventu
graft
reject
agreement
observ
complet
graft
accept
use
allogen
tumor
model
wherea
skin
transplant
eventu
reject
albeit
delay
kinet
allogen
tumor
cell
popul
use
studi
diminish
stimulatori
properti
compar
skin
graft
sinc
harbor
allogen
profession
apc
greatli
enhanc
allorespons
skin
transplant
surviv
significantli
longer
signal
absent
cell
profound
graft
surviv
observ
signal
simultan
lost
see
appreci
effect
costimul
provid
vitro
presum
sourc
costimul
receiv
late
rescu
apoptot
cell
express
low
cell
upregul
sever
day
antigen
stimul
note
find
reminisc
describ
vari
level
costimul
restor
pkctheta
defici
cell
respons
allogen
heart
addit
provid
acut
toler
allogen
transplant
essenti
goal
prevent
chronic
allograft
reject
without
impos
longterm
blockad
convent
immun
respons
order
maintain
allograft
surviv
long
period
time
eg
remain
lifetim
transplant
recipi
tmem
respons
alloantigen
must
repress
delet
studi
demonstr
initi
interact
cell
alloantigen
lead
delet
alloreact
cell
consequ
drastic
affect
shortand
longterm
recal
respons
earli
post
activ
cell
fail
effici
respond
allogen
tumor
even
post
transplant
product
significantli
diminish
rechalleng
alloantigen
previou
report
link
suboptim
cell
activ
diminish
memori
pool
format
viral
alter
peptid
ligand
model
data
stress
import
optim
cell
activ
condit
provid
longterm
tmem
surviv
w
e
previous
demonstr
requir
gener
antivir
tmem
perhap
due
highli
inflammatori
natur
antivir
respons
contrast
vital
alloreact
tmem
gener
transplant
model
test
cell
popul
possess
drastic
reduc
tmem
pool
provid
evid
blockad
may
impact
acut
reject
also
help
minim
chronic
reject
mediat
alloreact
memori
cell
protein
kinas
plausibl
small
molecul
antagonist
may
synthes
specif
block
intracellular
activ
find
suggest
blockad
may
greatest
therapeut
potenti
costimulatori
signal
limit
either
avail
surfac
graft
due
type
transplant
administr
consequ
recipi
weakli
immunogen
graft
pancreat
islet
stem
cell
may
benefit
mere
block
alon
wherea
vascular
tissu
organ
transplant
bear
allogen
apc
may
requir
combin
therapi
signal
inhibit
distinct
current
immunosuppress
regimen
blockad
may
thu
promot
select
delet
alloreact
cell
clone
prevent
memori
format
without
neg
impact
antivir
immun
refer
web
version
pubm
central
supplementari
materi
defici
lead
enhanc
surviv
allogen
skin
graft
decreas
allogen
memori
wt
transplant
situ
ear
skin
allogen
balbc
mice
graft
surviv
monitor
daili
consid
reject
necrot
p
n
wt
b
allogen
balbc
skin
transplant
onto
wt
prior
tmem
enrich
deplet
spleen
transfer
receiv
skin
graft
prior
p
n
c
wildtyp
transplant
allogen
skin
prior
retriev
spleen
splenocyt
label
ab
prior
fac
p
p
use
unpair
student
test
costimul
blockad
use
synerg
defici
lead
long
term
allogen
skin
graft
surviv
wt
transplant
ear
skin
allogen
balbc
mice
treat
start
day
transplant
p
wt
treat
b
wt
cell
transfer
previous
receiv
allogen
skin
transplant
prior
mice
treat
start
day
adopt
transfer
p
mice
per
condit
